Immunoparesis in symptomatic multiple myeloma at diagnosis affects PFS with bortezomib-containing induction therapy, but not ASCT consolidation.Published in:2019By:Gao, Wen;Li, Jie;Jian, Yuan;Yang, Guangzong;Wu, Yin;Li, Yanchen;Len, Yun;Liu, Aijun;Tian, Ying;Wang, Huijuan;Zhou, Huixing;Zhang, Zhiyao;Chen, WenmingPublication type:journal article